NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/07/2026
Voltar para busca
Dado oficial do USPTO
ATTENUBIOTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ATTENUBIOTICS
ST13
US500000090304009Classe
5, 31
Pedido
90304009
Registro
8330354
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
71
Atualização mais recente
07/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 31
Data de depósito
06/11/2020
Data de registro
07/07/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/07/2026
Última transação
07/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
03
Localização do titular
Calgary, Alberta, CA
Examinador
WRIGHT, MARCO JABBAR
Unidade examinadora
N20
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Attenubiotics Inc.
Representantes
Lisa M. Caldwell Klarquist Sparkman, LLP
Classificação técnica
Classes Nice
Classe 5Classe 31
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Nutritional supplements for general health and well-being; nutritional supplements for animal foodstuffs; animal feed additives for use as nutritional supplements; animal feed supplements; Pharmaceutical preparations for the prevention and treatment of pathogenic infections in humans and animals caused by pathogenic agents in humans and animalsnamely preparations for inhibiting the production or bioavailability of adenosine triphosphate (ATP) required for replication of the pathogenic agents to provide the host organism the time to mount an effective immune response to the pathogenic agents without being overwhelmed with exponential pathogenic replication of the pathogenic agents; Pharmaceutical preparations for the prevention and treatment of pathogenic infectionsnamely pharmaceutical preparations for attenuation of pathogen replication cycles in humans and animals; Pharmaceutical preparations for the prevention and treatment of pathogenic infections in humans and animalsnamely pharmaceutical preparations for regulating the immune system
Classe 31
Animal feed
Publicações
Histórico de despachos e eventos da marca no USPTO.
71 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/05/2026
PUBO
PUBLISHED FOR OPPOSITION
19/05/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/05/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/04/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/04/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/04/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/04/2026
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/01/2026
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/01/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/10/2025
GNRT
NON-FINAL ACTION E-MAILED
14/10/2025
CNRT
NON-FINAL ACTION WRITTEN
14/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/09/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/09/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
16/06/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
16/06/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/03/2025
GNRT
NON-FINAL ACTION E-MAILED
17/03/2025
CNRT
NON-FINAL ACTION WRITTEN
17/03/2025
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
17/03/2025
OTHE
CASE RETURNED TO EXAMINATION
06/03/2025
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
06/03/2025
APET
ASSIGNED TO PETITION STAFF
05/03/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
25/01/2025
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
23/01/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/07/2024
EX5G
SOU EXTENSION 5 GRANTED
19/07/2024
EXT5
SOU EXTENSION 5 FILED
19/07/2024
EEXT
SOU TEAS EXTENSION RECEIVED
19/07/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19/01/2024
EX4G
SOU EXTENSION 4 GRANTED
17/01/2024
EXT4
SOU EXTENSION 4 FILED
17/01/2024
EEXT
SOU TEAS EXTENSION RECEIVED
17/01/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/08/2023
EX3G
SOU EXTENSION 3 GRANTED
01/08/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/08/2023
EXT3
SOU EXTENSION 3 FILED
24/07/2023
EEXT
SOU TEAS EXTENSION RECEIVED
24/07/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
24/07/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/07/2023
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
24/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/07/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21/01/2023
EX2G
SOU EXTENSION 2 GRANTED
19/01/2023
EXT2
SOU EXTENSION 2 FILED
19/01/2023
EEXT
SOU TEAS EXTENSION RECEIVED
19/01/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19/07/2022
EX1G
SOU EXTENSION 1 GRANTED
15/07/2022
EXT1
SOU EXTENSION 1 FILED
15/07/2022
EEXT
SOU TEAS EXTENSION RECEIVED
15/07/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
25/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/11/2021
PUBO
PUBLISHED FOR OPPOSITION
30/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/10/2021
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
20/04/2021
GPRA
PRIORITY ACTION E-MAILED
20/04/2021
CPRA
PRIORITY ACTION WRITTEN
20/04/2021
DOCK
ASSIGNED TO EXAMINER
13/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2021
NWAP
NEW APPLICATION ENTERED
10/11/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ATTENUBIOTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.